Twist Bioscience Corporation Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent
Twist Bioscience Corporation (TWST) reported Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent of 0.00% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther · last filed 2025-11-17
- Twist Bioscience Corporation effective income tax rate reconciliation, tax credit, other, percent for fiscal 2025 was 0.00%.
- Twist Bioscience Corporation effective income tax rate reconciliation, tax credit, other, percent for fiscal 2024 was 0.00%, a 100.00% decline from fiscal 2023.
- Twist Bioscience Corporation effective income tax rate reconciliation, tax credit, other, percent for fiscal 2023 was 2.00%.
- Twist Bioscience Corporation effective income tax rate reconciliation, tax credit, other, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent 12 month as first filed |
|---|---|---|
| 2025-09-30 | 0.00% 10-K · filed 2025-11-17 | |
| 2024-09-30 | 0.00% 10-K · filed 2025-11-17 | 1.00% 10-K · filed 2024-11-18 |
| 2023-09-30 | 2.00% 10-K · filed 2025-11-17 | -2.00% 10-K · filed 2023-11-21 |
| 2022-09-30 | 0.00% 10-K · filed 2024-11-18 | |
| 2021-09-30 | 0.00% 10-K · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |